Search

German Cancer Research Center, Kilimanjaro Christian Medical Centre,Moshi,Tanzania, and Oliver Henke, Head of Working Group Global Oncology, Section Global Health, University Hospital Bonn

University Hospital, Aachen, University Hospital, Bonn, University Hospital of Cologne, University Hospital, Essen, University Hospital Muenster, and German Cancer Research Center

Institut National de la Santé Et de la Recherche Médicale, France, University Hospital Tuebingen, University of Florence, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, University Of Perugia, German Cancer Research Center, Karolinska Institutet, Maria Sklodowska-Curie National Research Institute of Oncology, Institut Curie, Medical University of Gdansk, Princess Maxima Center for Pediatric Oncology, and Catalan Institute of Oncology, Barcelona

Tubingen University Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Fondazione IRCCS ISTITUTO NAZIONALE TUMORI, Hospital Clinic of Barcelona, Istanbul University, University Of Perugia, German Cancer Research Center, and Daniela Massi, Professor

Gustave Roussy, Cancer Campus, Grand Paris, German Cancer Research Center, Oslo universitetssykehus HF, The Netherlands Cancer Institute, Hospital del Mar Research Institute, Istituto Europeo di Oncologia, European Organisation for Research and Treatment of Cancer - EORTC, UNICANCER, EAPC, Institut Curie, EUROPEAN CANCER ORGANISATION, DIGICORE/IFO, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Alleanza Contro il Cancro, Istituti Fisioterapici Ospitalieri, STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG, University of Milan, SporeData OÜ, ORGANISATION OF EUROPEAN CANCER INSTITUTES, FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA, Medical University Innsbruck, SDRUZHENIE ASOTSIATSIA NA PATSIENTITE SONKOLOGICHNI ZABOLYAVANIA I PRIYATELI, FEDERATIA ASOCIATIILOR BOLNAVILOR DE CANCER, University of Leeds, The Leeds Teaching Hospitals NHS Trust, and Region Hovedstaden (Bispebjerg Hospital & Rigshospitalet)

KKS Dresden and German Cancer Research Center

German Cancer Research Center, H. Lee Moffitt Cancer Center and Research Institute, Huntsman Cancer Institute, Cedars-Sinai Medical Center, Washington University School of Medicine, University of Tennessee, and Cornelia Ulrich, PhD

German Cancer Research Center

KKS Dresden and German Cancer Research Center

German Cancer Research Center

Molecular Health GmbH, German Cancer Research Center, Nationales Centrum für Tumorerkrankungen, Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Institut für Medizinische Biometrie, and John Neoptolemos, Prof. Dr. med.

AstraZeneca, PharmaMar, and German Cancer Research Center

Children's Cancer Institute Australia, Australian & New Zealand Children's Haematology/Oncology Group, Garvan Institute of Medical Research, German Cancer Research Center, and Dr David Ziegler, Professor

German Cancer Research Center, National Center for Radiation Research in Oncology Dresden/Heidelberg, and Mechthild Krause, Principal Investigator

DRK Blutspendedienst Baden-Württemberg-Hessen gGmbH, Georg-Speyer-Haus, LOEWE Center Frankfurt Cancer Institute, German Cancer Research Center, and Michael Burger, Principal Investigator

German Cancer Research Center

German Cancer Research Center

German Cancer Research Center, German Sport University Cologne (DSHS), Cologne, Germany, Cabrini Health (CAB), Malvern, Australia, Karolinska Institute (KI), Stockholm, Sweden, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands, Heidelberg University Clinic and National Center for Tumor Diseases, Heidelberg, Germany, Fundacion Onkologikao (ONK), San Sebastian, Spain, Associação de Investigação e Cuidados de Suporte em Oncologia (AISCO), Nova de Gaia, Portugal, and Dr. Anne May, Prof. Dr.

Helmholtz Zentrum München, German Cancer Research Center, Ludwig-Maximilians - University of Munich, Hannover Medical School, University Hospital Freiburg, and German Center for Infection Research

German Cancer Research Center and Olaf Witt, MD, Prof. Dr. Olaf Witt

University Hospital Tuebingen, Ludwig-Maximilians - University of Munich, German Cancer Research Center, and Juergen Debus, Head of Department

German Cancer Research Center, Australian Catholic University, Karolinska Institutet, The Netherlands Cancer Institute, Medical University of Gdansk, Fundación Onkologikoa Fundazioa, Europa Donna, German Sport University, Cologne, University Hospital Heidelberg, Nurogames GmbH, Cologne, and Dr. Anne May, Cancer Epidemiologist

German Cancer Research Center, Universität Tübingen, University Hospital Tuebingen, and Peter Lang, Prof. Dr. med.

GPOH Consortium Sickle Cell Disease, Johann Wolfgang Goethe University Hospital, Universitätsklinikum Hamburg-Eppendorf, University Hospital Ulm, Charite University, Berlin, Germany, German Cancer Research Center, Deutsche Kinderkrebsstiftung, Pfizer, and Dr. Joachim Kunz, Senior physician

German Cancer Research Center

Array BioPharma, German Cancer Research Center, Coordinating Centre for Clinical Trials Heidelberg, University Hospital Heidelberg, and Marc Raab, PD Dr. med

German Cancer Research Center and Niels Halama, Principal Investigator, Head of Department Translational Immunotherapy

German Cancer Aid, German Cancer Research Center, National Center for Tumor Diseases, Heidelberg, and Prof. Dr. Wolfgang Wick, Coordinating Investigator

All India Institute of Medical Sciences, New Delhi, Cancer Foundation of India, Christian Fellowship Community Health Centre, German Cancer Research Center, Gujarat Cancer & Research Institute, Jehangir Clinical Development Centre, MNJ Institute of Oncology & Regional cancer Center, Rajiv Gandhi Centre for Biotechnology, Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Tata Memorial Centre, and Partha Basu, Early Detection, Prevention and Infection Branch at IARC, WHO

German Cancer Research Center, National Center for Tumor Diseases (NCT) Dresden, National Center for Tumor Diseases, Heidelberg, Radiation Oncology Working Group of the German Cancer Society, and Mechthild Krause, Director of the Department of Radiotherapy and Radiation Oncology

Helmholtz Munich, Munich, German Cancer Research Center, and Charité University Hospital, Berlin, Germany

German Cancer Research Center, Heidelberg University, and Dr. med. Seyer Safi, PD Dr. med. Seyer Safi

University Hospital Dresden, German Cancer Research Center, and Georg Martin Haag, NCT, Dep. Medical Oncology

Ph.D. Student Niklas Holzwarth, Inteligent Medical Systems, German Cancer Research Center and Ulrich Rother, PD Dr. med.

German Cancer Research Center, University of Heidelberg Medical Center, National Center for Tumor Diseases, Heidelberg, German Cancer Aid, and Nadine Ungar, Dr.

National Center for Tumor Diseases, Heidelberg, German Cancer Research Center, Heidelberg University, University of Cologne, Universitätsmedizin Mannheim, and Michael Dill, Principal Investigator

University Hospital Dresden, German Cancer Research Center, and Prof. Dr. Richard F Schlenk, Head of NCT trials center

German Cancer Research Center, Radiation Oncology Working Group of the German Cancer Society, and Mechthild Krause, Principal Investigator

German Cancer Research Center, Heidelberg University, and Dr. med. Seyer Safi, Dr. med. Seyer Safi

Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany, Division of Computer Assisted Medical Interventions, German Cancer Research Center, Heidelberg, Germany, and Ulrich Rother, PD Dr. med.

German Cancer Research Center and Niels Halama, Head of Department Translational Immunotherapy DKFZ

German Cancer Research Center, National Center for Radiation Research in Oncology Dresden/Heidelberg, and Prof. Esther Troost, Prof. Esther Troost

Janssen-Cilag G.m.b.H, Labor Berlin-Charité Vivantes G.m.b.H, German Cancer Research Center, Charité Clinical Trial Office (CTO), and Tobias Alexander, Tobias Alexander, Principal investigator

Universitätsmedizin Mannheim, Klinikum Frankfurt Höchst, German Cancer Research Center, GlaxoSmithKline, University Hospital Heidelberg, and Peter Hohenberger, Head, Division of Surgical Oncology and Thoracic Surgery

German Cancer Research Center, Janssen-Cilag International NV, Mundipharma Research GmbH & Co KG, inVentiv Health Clinical, and Dr. Marc Raab, Marc S. Raab MD, Medical Hospital V (Hematology, Oncology, Rheumatology), Section multiple myeloma

German Cancer Research Center and Juergen Debus, Prof. Dr. Dr.

Heidelberg University, German Cancer Research Center, Astellas Pharma US, Inc., Novartis, and Prof. Dr. Rolf Weimer, head of renal transplant program, University of Giessen

King's College London, German Cancer Research Center, Maastricht University, University of Athens, AER PUR ROMANIA, European Respiratory Society, University of Waterloo, Institut Català d'Oncologia, DOHANYZAS VAGY EGESZSEG MAGYAR ALAPITVANY, PROMOCJA ZDROWIA - ZDROWIE ALBO TYTON FUNDACJA, University of Crete, and TNS OPINION SA

University Hospital Heidelberg, German Cancer Research Center, and Neuro-Oncology Working Group of the German Cancer Society

Imperial College London, Centre for Research in Epidemiology and Population Health (CESP), Gustave Roussy, Cancer Campus, Grand Paris, German Cancer Research Center, German Institute of Human Nutrition, Hellenic Health Foundation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Cancer Prevention and Research Institute, Italy, Federico II University, Center for Cancer Prevention (CPO), and Azienda Sanitaria Provinciale Ragusa